The U.S. Department of Justice’s Antitrust Division, joined by the Ohio Attorney General, has filed a civil antitrust suit against OhioHealth, alleging the health system used contracting practices that unlawfully restricted competition and increased healthcare costs. The case, United States of America et al v. OhioHealth Corporation, puts a spotlight on how enforcers are continuing to scrutinize not just mergers, but also the day-to-day terms health systems negotiate with commercial payers.

That distinction matters. In recent years, antitrust attention in healthcare has often centered on consolidation and acquisition activity. This lawsuit signals that regulators remain equally focused on post-merger or standalone contracting behavior—especially provisions that allegedly limit insurers’ ability to steer patients, design networks, or create lower-cost benefit options that could advantage rival providers. For hospitals and integrated systems, the government’s theory underscores that contracting practices once viewed as aggressive but routine may now be framed as exclusionary conduct.

For litigators, the case is worth watching for how the government pleads competitive harm in a healthcare-services market without relying on a merger challenge. The complaint may offer a roadmap for future enforcement actions targeting payer/provider agreements, including provisions involving steering, tiering, and network design. It may also provide insight into how federal and state enforcers coordinate in civil antitrust matters when local healthcare markets are at issue.

For in-house counsel and compliance teams, the message is practical: hospital contract templates, payer negotiations, and internal sales strategies may deserve renewed antitrust review. Clauses that affect insurer flexibility, patient incentives, or rival access to commercially important networks can create risk even absent a headline-grabbing transaction. Compliance teams should also note the broader enforcement environment, where healthcare pricing and access remain politically and economically sensitive issues.

The filing against OhioHealth may become an important test case for courts evaluating whether provider contract restrictions cross the line from hard bargaining into unlawful restraints on competition. Legal departments representing health systems, payers, and provider groups should monitor the docket closely, both for the court’s treatment of the alleged conduct and for clues about where antitrust enforcers may look next. The Southern District of Ohio docket is available here: United States of America et al v. OhioHealth Corporation.